All Journals > Clinical Infectious Diseases > 1 March 2007 > Metabolic Syndrome in HIV Infection

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

1 March 2007

Volume 44, Number 5
Clinical Infectious Diseases 2007;44:726–734
1058-4838/2007/4405-0018$15.00
DOI: 10.1086/511679
HIV/AIDS MAJOR ARTICLE

Metabolic Syndrome in HIV‐Infected Patients from an Urban, Midwestern US Outpatient Population

Kristin Mondy,1

Edgar Turner Overton,1

Jessica Grubb,1

Shao Tong,1

Warren Seyfried,1

William Powderly,2

Kevin Yarasheski1

1Washington University School of Medicine, St. Louis, Missouri, and 2University College Dublin School of Medicine and Medical Science, Dublin, Ireland

Background.The association between the use of highly active antiretroviral therapy (HAART) and an increased risk of metabolic syndrome and cardiovascular disease remains unclear.

Methods.We conducted a prospective, cross‐sectional study of the risk factors associated with metabolic syndrome and cardiovascular disease among patients from an urban outpatient human immunodeficiency virus (HIV) clinic. Evaluation included laboratory data that were obtained after an overnight fast and a health survey that assessed traditional risk factors associated with cardiovascular disease, HIV‐related factors, and comorbidities. Data collected were compared with data files from a cohort from the National Health and Nutrition Examination Survey (NHANES; 2001–2002) of persons who were seronegative for HIV infection who were matched for age, sex, race, and tobacco use.

Results.Four hundred seventy‐one HIV‐infected subjects provided complete data. The overall prevalence of metabolic syndrome was similar between the group HIV‐infected patients and the group of persons who were seronegative for HIV infection (25.5% vs. 26.5%, respectively), although the HIV‐infected patients had a significantly smaller waist circumference, lower body mass index, lower high‐density lipoprotein cholesterol levels, higher triglyceride levels, and lower glucose levels, compared with the subjects from the NHANES cohort. Framingham 10‐year risk scores were also similar between the 2 groups. HIV‐infected patients with metabolic syndrome were more likely to be diabetic, older, and white and have a high CD4 cell count and body mass index, compared with patients without metabolic syndrome ( for all). The type or duration of antiretroviral therapy was not an independent risk factor for metabolic syndrome.

Conclusions.The prevalence of metabolic syndrome is high among HIV‐infected persons, but not higher than the prevalence among HIV‐uninfected persons. Traditional risk factors play a more significant role in the development of metabolic syndrome than do HIV treatment–associated factors.

Received 17 July 2006; accepted 12 October 2006; electronically published 22 January 2007.

  • (See the editorial commentary by Jones on pages 735–8)

Reprints or correspondence: Dr. Kristin Mondy, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8011, St. Louis, MO 63108 ().

Cited by

Katherine Samaras. (2009) HIV, insulin resistance and cardiovascular disease. Current Cardiovascular Risk Reports 3:1, 59-64
Online publication date: 1-Feb-2009.
CrossRef
Cynthia L Gibert, Judith C Shlay, Shweta Sharma, Glenn Bartsch, Grace Peng, Carl Grunfeld. (2009) Racial Differences in Changes of Metabolic Parameters and Body Composition in Antiretroviral Therapy-Naive Persons Initiating Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:1, 44-53
Online publication date: 1-Feb-2009.
CrossRef
Oluwatoyin Adeyemi, Katayoun Rezai, Mieoak Bahk, Sheila Badri, Neena Thomas-Gossain. (2009) Metabolic Syndrome in Older HIV-Infected Patients: Data from the CORE50 Cohort. AIDS Patient Care and STDs 22:12, 941-945
Online publication date: 1-Jan-2009.
CrossRef
Paul W Hruz. (2008) HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models. Current Opinion in HIV and AIDS 3:6, 660-665
Online publication date: 1-Dec-2008.
CrossRef
Pablo Tebas. (2008) Insulin Resistance and Diabetes Mellitus Associated With Antiretroviral Use in HIV-Infected Patients: Pathogenesis, Prevention, and Treatment Options. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:Supplement 2, S86-S92
Online publication date: 1-Oct-2008.
CrossRef
Kavita P. Bhavan, Vinay N. Kampalath, Edgar Turner Overton. (2008) The aging of the HIV epidemic. Current HIV/AIDS Reports 5:3, 150-158
Online publication date: 1-Sep-2008.
CrossRef
Magdalena E Sobieszczyk, Donald R Hoover, Kathryn Anastos, Kathleen Mulligan, Tianren Tan, Qiuhu Shi, Wei Gao, Charles Hyman, Mardge H Cohen, Stephen R Cole, Michael W Plankey, Alexandra M Levine, Jessica Justman. (2008) Prevalence and Predictors of Metabolic Syndrome Among HIV-Infected and HIV-Uninfected Women in the Womens Interagency HIV Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:3, 272-280
Online publication date: 1-Aug-2008.
CrossRef
Caroline A Sabin, Signe W Worm. (2008) Conventional cardiovascular risk factors in HIV infection: how conventional are they?. Current Opinion in HIV and AIDS 3:3, 214-219
Online publication date: 1-Jun-2008.
CrossRef
Vivian Pao, Grace A. Lee, Carl Grunfeld. (2008) HIV therapy, metabolic syndrome, and cardiovascular risk. Current Atherosclerosis Reports 10:1, 61-70
Online publication date: 1-Feb-2008.
CrossRef
Colleen Hadigan, James Liebau, Rebecca Andersen, Nagaraj-Setty Holalkere, Dushyant V Sahani. (2007) Magnetic Resonance Spectroscopy of Hepatic Lipid Content and Associated Risk Factors in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:3, 312-317
Online publication date: 1-Dec-2007.
CrossRef
Handan Wand, Alexandra Calmy, Dianne L Carey, Katherine Samaras, Andrew Carr, Matthew G Law, David A Cooper, Sean Emery. (2007) Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 21:18, 2445-2453
Online publication date: 1-Dec-2007.
CrossRef
Julian Falutz. (2007) Therapy Insight: body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy. Nature Clinical Practice Endocrinology & Metabolism 3:9, 651-661
Online publication date: 1-Oct-2007.
CrossRef
Paolo Bonfanti, Cristina Giannattasio, Elena Ricci, Rita Facchetti, Elena Rosella, Marzia Franzetti, Laura Cordier, Luigi Pusterla, Michele Bombelli, Roberto Sega, Tiziana Quirino, Giuseppe Mancia. (2007) HIV and Metabolic Syndrome. JAIDS Journal of Acquired Immune Deficiency Syndromes 45:4, 426-431
Online publication date: 1-Sep-2007.
CrossRef
Jacqueline Capeau. (2007) From lipodystrophy and insulin resistance to metabolic syndrome: HIV infection, treatment and aging. Current Opinion in HIV and AIDS 2:4, 247-252
Online publication date: 1-Aug-2007.
CrossRef
Clara Y. Jones. (2007) Editorial Commentary: Metabolic Syndrome in HIV‐Infected Patients: No Different than the General Population?. Clinical Infectious Diseases 44:5, 735-738
Online publication date: 1-Mar-2007.
Close Popup